HOLLISTON, Mass., July 26, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the three and six months ended June 30, 2010 before market trading hours on Thursday, August 5, 2010.
